1 Study Coverage 1.1 MRD (Minimal Residual Disease) Testing Product Introduction 1.2 Market by Type 1.2.1 Global MRD (Minimal Residual Disease) Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Flow Cytometry 1.2.3 Polymerase Chain Reaction (PCR) 1.2.4 Next-Generation Sequencing (NGS) 1.3 Market by Application 1.3.1 Global MRD (Minimal Residual Disease) Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Specialty Clinics and Hospitals 1.3.3 Diagnostic Laboratories 1.3.4 Research Institutions 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global MRD (Minimal Residual Disease) Testing Sales Estimates and Forecasts 2017-2028 2.2 Global MRD (Minimal Residual Disease) Testing Revenue Estimates and Forecasts 2017-2028 2.3 Global MRD (Minimal Residual Disease) Testing Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global MRD (Minimal Residual Disease) Testing Sales by Region 2.4.1 Global MRD (Minimal Residual Disease) Testing Sales by Region (2017-2022) 2.4.2 Global Sales MRD (Minimal Residual Disease) Testing by Region (2023-2028) 2.5 Global MRD (Minimal Residual Disease) Testing Revenue by Region 2.5.1 Global MRD (Minimal Residual Disease) Testing Revenue by Region (2017-2022) 2.5.2 Global MRD (Minimal Residual Disease) Testing Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global MRD (Minimal Residual Disease) Testing Sales by Manufacturers 3.1.1 Global Top MRD (Minimal Residual Disease) Testing Manufacturers by Sales (2017-2022) 3.1.2 Global MRD (Minimal Residual Disease) Testing Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of MRD (Minimal Residual Disease) Testing in 2021 3.2 Global MRD (Minimal Residual Disease) Testing Revenue by Manufacturers 3.2.1 Global MRD (Minimal Residual Disease) Testing Revenue by Manufacturers (2017-2022) 3.2.2 Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by MRD (Minimal Residual Disease) Testing Revenue in 2021 3.3 Global MRD (Minimal Residual Disease) Testing Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global MRD (Minimal Residual Disease) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global MRD (Minimal Residual Disease) Testing Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global MRD (Minimal Residual Disease) Testing Sales by Type 4.1.1 Global MRD (Minimal Residual Disease) Testing Historical Sales by Type (2017-2022) 4.1.2 Global MRD (Minimal Residual Disease) Testing Forecasted Sales by Type (2023-2028) 4.1.3 Global MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2017-2028) 4.2 Global MRD (Minimal Residual Disease) Testing Revenue by Type 4.2.1 Global MRD (Minimal Residual Disease) Testing Historical Revenue by Type (2017-2022) 4.2.2 Global MRD (Minimal Residual Disease) Testing Forecasted Revenue by Type (2023-2028) 4.2.3 Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Type (2017-2028) 4.3 Global MRD (Minimal Residual Disease) Testing Price by Type 4.3.1 Global MRD (Minimal Residual Disease) Testing Price by Type (2017-2022) 4.3.2 Global MRD (Minimal Residual Disease) Testing Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global MRD (Minimal Residual Disease) Testing Sales by Application 5.1.1 Global MRD (Minimal Residual Disease) Testing Historical Sales by Application (2017-2022) 5.1.2 Global MRD (Minimal Residual Disease) Testing Forecasted Sales by Application (2023-2028) 5.1.3 Global MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2017-2028) 5.2 Global MRD (Minimal Residual Disease) Testing Revenue by Application 5.2.1 Global MRD (Minimal Residual Disease) Testing Historical Revenue by Application (2017-2022) 5.2.2 Global MRD (Minimal Residual Disease) Testing Forecasted Revenue by Application (2023-2028) 5.2.3 Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Application (2017-2028) 5.3 Global MRD (Minimal Residual Disease) Testing Price by Application 5.3.1 Global MRD (Minimal Residual Disease) Testing Price by Application (2017-2022) 5.3.2 Global MRD (Minimal Residual Disease) Testing Price Forecast by Application (2023-2028) 6 North America 6.1 North America MRD (Minimal Residual Disease) Testing Market Size by Type 6.1.1 North America MRD (Minimal Residual Disease) Testing Sales by Type (2017-2028) 6.1.2 North America MRD (Minimal Residual Disease) Testing Revenue by Type (2017-2028) 6.2 North America MRD (Minimal Residual Disease) Testing Market Size by Application 6.2.1 North America MRD (Minimal Residual Disease) Testing Sales by Application (2017-2028) 6.2.2 North America MRD (Minimal Residual Disease) Testing Revenue by Application (2017-2028) 6.3 North America MRD (Minimal Residual Disease) Testing Market Size by Country 6.3.1 North America MRD (Minimal Residual Disease) Testing Sales by Country (2017-2028) 6.3.2 North America MRD (Minimal Residual Disease) Testing Revenue by Country (2017-2028) 6.3.3 United States 6.3.4 Canada 7 Europe 7.1 Europe MRD (Minimal Residual Disease) Testing Market Size by Type 7.1.1 Europe MRD (Minimal Residual Disease) Testing Sales by Type (2017-2028) 7.1.2 Europe MRD (Minimal Residual Disease) Testing Revenue by Type (2017-2028) 7.2 Europe MRD (Minimal Residual Disease) Testing Market Size by Application 7.2.1 Europe MRD (Minimal Residual Disease) Testing Sales by Application (2017-2028) 7.2.2 Europe MRD (Minimal Residual Disease) Testing Revenue by Application (2017-2028) 7.3 Europe MRD (Minimal Residual Disease) Testing Market Size by Country 7.3.1 Europe MRD (Minimal Residual Disease) Testing Sales by Country (2017-2028) 7.3.2 Europe MRD (Minimal Residual Disease) Testing Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific MRD (Minimal Residual Disease) Testing Market Size by Type 8.1.1 Asia Pacific MRD (Minimal Residual Disease) Testing Sales by Type (2017-2028) 8.1.2 Asia Pacific MRD (Minimal Residual Disease) Testing Revenue by Type (2017-2028) 8.2 Asia Pacific MRD (Minimal Residual Disease) Testing Market Size by Application 8.2.1 Asia Pacific MRD (Minimal Residual Disease) Testing Sales by Application (2017-2028) 8.2.2 Asia Pacific MRD (Minimal Residual Disease) Testing Revenue by Application (2017-2028) 8.3 Asia Pacific MRD (Minimal Residual Disease) Testing Market Size by Region 8.3.1 Asia Pacific MRD (Minimal Residual Disease) Testing Sales by Region (2017-2028) 8.3.2 Asia Pacific MRD (Minimal Residual Disease) Testing Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 China Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 9 Latin America 9.1 Latin America MRD (Minimal Residual Disease) Testing Market Size by Type 9.1.1 Latin America MRD (Minimal Residual Disease) Testing Sales by Type (2017-2028) 9.1.2 Latin America MRD (Minimal Residual Disease) Testing Revenue by Type (2017-2028) 9.2 Latin America MRD (Minimal Residual Disease) Testing Market Size by Application 9.2.1 Latin America MRD (Minimal Residual Disease) Testing Sales by Application (2017-2028) 9.2.2 Latin America MRD (Minimal Residual Disease) Testing Revenue by Application (2017-2028) 9.3 Latin America MRD (Minimal Residual Disease) Testing Market Size by Country 9.3.1 Latin America MRD (Minimal Residual Disease) Testing Sales by Country (2017-2028) 9.3.2 Latin America MRD (Minimal Residual Disease) Testing Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa MRD (Minimal Residual Disease) Testing Market Size by Type 10.1.1 Middle East and Africa MRD (Minimal Residual Disease) Testing Sales by Type (2017-2028) 10.1.2 Middle East and Africa MRD (Minimal Residual Disease) Testing Revenue by Type (2017-2028) 10.2 Middle East and Africa MRD (Minimal Residual Disease) Testing Market Size by Application 10.2.1 Middle East and Africa MRD (Minimal Residual Disease) Testing Sales by Application (2017-2028) 10.2.2 Middle East and Africa MRD (Minimal Residual Disease) Testing Revenue by Application (2017-2028) 10.3 Middle East and Africa MRD (Minimal Residual Disease) Testing Market Size by Country 10.3.1 Middle East and Africa MRD (Minimal Residual Disease) Testing Sales by Country (2017-2028) 10.3.2 Middle East and Africa MRD (Minimal Residual Disease) Testing Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 ICON plc 11.1.1 ICON plc Corporation Information 11.1.2 ICON plc Overview 11.1.3 ICON plc MRD (Minimal Residual Disease) Testing Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 ICON plc MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 ICON plc Recent Developments 11.2 ArcherDX(Invitae) 11.2.1 ArcherDX(Invitae) Corporation Information 11.2.2 ArcherDX(Invitae) Overview 11.2.3 ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 ArcherDX(Invitae) Recent Developments 11.3 ARUP Laboratories 11.3.1 ARUP Laboratories Corporation Information 11.3.2 ARUP Laboratories Overview 11.3.3 ARUP Laboratories MRD (Minimal Residual Disease) Testing Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 ARUP Laboratories MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 ARUP Laboratories Recent Developments 11.4 Asuragen 11.4.1 Asuragen Corporation Information 11.4.2 Asuragen Overview 11.4.3 Asuragen MRD (Minimal Residual Disease) Testing Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Asuragen MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Asuragen Recent Developments 11.5 Cergentis B.V. 11.5.1 Cergentis B.V. Corporation Information 11.5.2 Cergentis B.V. Overview 11.5.3 Cergentis B.V. MRD (Minimal Residual Disease) Testing Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Cergentis B.V. MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Cergentis B.V. Recent Developments 11.6 Bio-Rad Laboratories 11.6.1 Bio-Rad Laboratories Corporation Information 11.6.2 Bio-Rad Laboratories Overview 11.6.3 Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Bio-Rad Laboratories Recent Developments 11.7 Mission Bio 11.7.1 Mission Bio Corporation Information 11.7.2 Mission Bio Overview 11.7.3 Mission Bio MRD (Minimal Residual Disease) Testing Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Mission Bio MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Mission Bio Recent Developments 11.8 Guardant Health 11.8.1 Guardant Health Corporation Information 11.8.2 Guardant Health Overview 11.8.3 Guardant Health MRD (Minimal Residual Disease) Testing Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 Guardant Health MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Guardant Health Recent Developments 11.9 Invivoscribe 11.9.1 Invivoscribe Corporation Information 11.9.2 Invivoscribe Overview 11.9.3 Invivoscribe MRD (Minimal Residual Disease) Testing Sales, Price, Revenue and Gross Margin (2017-2022) 11.9.4 Invivoscribe MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 Invivoscribe Recent Developments 11.10 LabCorp 11.10.1 LabCorp Corporation Information 11.10.2 LabCorp Overview 11.10.3 LabCorp MRD (Minimal Residual Disease) Testing Sales, Price, Revenue and Gross Margin (2017-2022) 11.10.4 LabCorp MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 LabCorp Recent Developments 11.11 Inivata 11.11.1 Inivata Corporation Information 11.11.2 Inivata Overview 11.11.3 Inivata MRD (Minimal Residual Disease) Testing Sales, Price, Revenue and Gross Margin (2017-2022) 11.11.4 Inivata MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications 11.11.5 Inivata Recent Developments 11.12 Natera 11.12.1 Natera Corporation Information 11.12.2 Natera Overview 11.12.3 Natera MRD (Minimal Residual Disease) Testing Sales, Price, Revenue and Gross Margin (2017-2022) 11.12.4 Natera MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications 11.12.5 Natera Recent Developments 11.13 NeoGenomics Laboratories 11.13.1 NeoGenomics Laboratories Corporation Information 11.13.2 NeoGenomics Laboratories Overview 11.13.3 NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Sales, Price, Revenue and Gross Margin (2017-2022) 11.13.4 NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications 11.13.5 NeoGenomics Laboratories Recent Developments 11.14 Opko Health 11.14.1 Opko Health Corporation Information 11.14.2 Opko Health Overview 11.14.3 Opko Health MRD (Minimal Residual Disease) Testing Sales, Price, Revenue and Gross Margin (2017-2022) 11.14.4 Opko Health MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications 11.14.5 Opko Health Recent Developments 11.15 Quest Diagnostics 11.15.1 Quest Diagnostics Corporation Information 11.15.2 Quest Diagnostics Overview 11.15.3 Quest Diagnostics MRD (Minimal Residual Disease) Testing Sales, Price, Revenue and Gross Margin (2017-2022) 11.15.4 Quest Diagnostics MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications 11.15.5 Quest Diagnostics Recent Developments 11.16 Sysmex Corporation 11.16.1 Sysmex Corporation Corporation Information 11.16.2 Sysmex Corporation Overview 11.16.3 Sysmex Corporation MRD (Minimal Residual Disease) Testing Sales, Price, Revenue and Gross Margin (2017-2022) 11.16.4 Sysmex Corporation MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications 11.16.5 Sysmex Corporation Recent Developments 11.17 Adaptive Biotechnologies 11.17.1 Adaptive Biotechnologies Corporation Information 11.17.2 Adaptive Biotechnologies Overview 11.17.3 Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Sales, Price, Revenue and Gross Margin (2017-2022) 11.17.4 Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications 11.17.5 Adaptive Biotechnologies Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 MRD (Minimal Residual Disease) Testing Industry Chain Analysis 12.2 MRD (Minimal Residual Disease) Testing Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 MRD (Minimal Residual Disease) Testing Production Mode & Process 12.4 MRD (Minimal Residual Disease) Testing Sales and Marketing 12.4.1 MRD (Minimal Residual Disease) Testing Sales Channels 12.4.2 MRD (Minimal Residual Disease) Testing Distributors 12.5 MRD (Minimal Residual Disease) Testing Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 MRD (Minimal Residual Disease) Testing Industry Trends 13.2 MRD (Minimal Residual Disease) Testing Market Drivers 13.3 MRD (Minimal Residual Disease) Testing Market Challenges 13.4 MRD (Minimal Residual Disease) Testing Market Restraints 14 Key Findings in The Global MRD (Minimal Residual Disease) Testing Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global MRD (Minimal Residual Disease) Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of Flow Cytometry Table 3. Major Manufacturers of Polymerase Chain Reaction (PCR) Table 4. Major Manufacturers of Next-Generation Sequencing (NGS) Table 5. Global MRD (Minimal Residual Disease) Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 6. Global MRD (Minimal Residual Disease) Testing Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million) Table 7. Global MRD (Minimal Residual Disease) Testing Sales by Region (2017-2022) & (Units) Table 8. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Region (2017-2022) Table 9. Global MRD (Minimal Residual Disease) Testing Sales by Region (2023-2028) & (Units) Table 10. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Region (2023-2028) Table 11. Global MRD (Minimal Residual Disease) Testing Revenue by Region (2017-2022) & (US$ Million) Table 12. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Region (2017-2022) Table 13. Global MRD (Minimal Residual Disease) Testing Revenue by Region (2023-2028) & (US$ Million) Table 14. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Region (2023-2028) Table 15. Global MRD (Minimal Residual Disease) Testing Sales by Manufacturers (2017-2022) & (Units) Table 16. Global MRD (Minimal Residual Disease) Testing Sales Share by Manufacturers (2017-2022) Table 17. Global MRD (Minimal Residual Disease) Testing Revenue by Manufacturers (2017-2022) & (US$ Million) Table 18. Global MRD (Minimal Residual Disease) Testing Revenue Share by Manufacturers (2017-2022) Table 19. MRD (Minimal Residual Disease) Testing Price by Manufacturers (2017-2022) &(US$/Unit) Table 20. Global MRD (Minimal Residual Disease) Testing Manufacturers Market Concentration Ratio (CR5 and HHI) Table 21. Global MRD (Minimal Residual Disease) Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in MRD (Minimal Residual Disease) Testing as of 2021) Table 22. MRD (Minimal Residual Disease) Testing Manufacturing Base Distribution and Headquarters Table 23. Manufacturers MRD (Minimal Residual Disease) Testing Product Offered Table 24. Date of Manufacturers Enter into MRD (Minimal Residual Disease) Testing Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global MRD (Minimal Residual Disease) Testing Sales by Type (2017-2022) & (Units) Table 27. Global MRD (Minimal Residual Disease) Testing Sales by Type (2023-2028) & (Units) Table 28. Global MRD (Minimal Residual Disease) Testing Sales Share by Type (2017-2022) Table 29. Global MRD (Minimal Residual Disease) Testing Sales Share by Type (2023-2028) Table 30. Global MRD (Minimal Residual Disease) Testing Revenue by Type (2017-2022) & (US$ Million) Table 31. Global MRD (Minimal Residual Disease) Testing Revenue by Type (2023-2028) & (US$ Million) Table 32. Global MRD (Minimal Residual Disease) Testing Revenue Share by Type (2017-2022) Table 33. Global MRD (Minimal Residual Disease) Testing Revenue Share by Type (2023-2028) Table 34. MRD (Minimal Residual Disease) Testing Price by Type (2017-2022) & (US$/Unit) Table 35. Global MRD (Minimal Residual Disease) Testing Price Forecast by Type (2023-2028) & (US$/Unit) Table 36. Global MRD (Minimal Residual Disease) Testing Sales by Application (2017-2022) & (Units) Table 37. Global MRD (Minimal Residual Disease) Testing Sales by Application (2023-2028) & (Units) Table 38. Global MRD (Minimal Residual Disease) Testing Sales Share by Application (2017-2022) Table 39. Global MRD (Minimal Residual Disease) Testing Sales Share by Application (2023-2028) Table 40. Global MRD (Minimal Residual Disease) Testing Revenue by Application (2017-2022) & (US$ Million) Table 41. Global MRD (Minimal Residual Disease) Testing Revenue by Application (2023-2028) & (US$ Million) Table 42. Global MRD (Minimal Residual Disease) Testing Revenue Share by Application (2017-2022) Table 43. Global MRD (Minimal Residual Disease) Testing Revenue Share by Application (2023-2028) Table 44. MRD (Minimal Residual Disease) Testing Price by Application (2017-2022) & (US$/Unit) Table 45. Global MRD (Minimal Residual Disease) Testing Price Forecast by Application (2023-2028) & (US$/Unit) Table 46. North America MRD (Minimal Residual Disease) Testing Sales by Type (2017-2022) & (Units) Table 47. North America MRD (Minimal Residual Disease) Testing Sales by Type (2023-2028) & (Units) Table 48. North America MRD (Minimal Residual Disease) Testing Revenue by Type (2017-2022) & (US$ Million) Table 49. North America MRD (Minimal Residual Disease) Testing Revenue by Type (2023-2028) & (US$ Million) Table 50. North America MRD (Minimal Residual Disease) Testing Sales by Application (2017-2022) & (Units) Table 51. North America MRD (Minimal Residual Disease) Testing Sales by Application (2023-2028) & (Units) Table 52. North America MRD (Minimal Residual Disease) Testing Revenue by Application (2017-2022) & (US$ Million) Table 53. North America MRD (Minimal Residual Disease) Testing Revenue by Application (2023-2028) & (US$ Million) Table 54. North America MRD (Minimal Residual Disease) Testing Sales by Country (2017-2022) & (Units) Table 55. North America MRD (Minimal Residual Disease) Testing Sales by Country (2023-2028) & (Units) Table 56. North America MRD (Minimal Residual Disease) Testing Revenue by Country (2017-2022) & (US$ Million) Table 57. North America MRD (Minimal Residual Disease) Testing Revenue by Country (2023-2028) & (US$ Million) Table 58. Europe MRD (Minimal Residual Disease) Testing Sales by Type (2017-2022) & (Units) Table 59. Europe MRD (Minimal Residual Disease) Testing Sales by Type (2023-2028) & (Units) Table 60. Europe MRD (Minimal Residual Disease) Testing Revenue by Type (2017-2022) & (US$ Million) Table 61. Europe MRD (Minimal Residual Disease) Testing Revenue by Type (2023-2028) & (US$ Million) Table 62. Europe MRD (Minimal Residual Disease) Testing Sales by Application (2017-2022) & (Units) Table 63. Europe MRD (Minimal Residual Disease) Testing Sales by Application (2023-2028) & (Units) Table 64. Europe MRD (Minimal Residual Disease) Testing Revenue by Application (2017-2022) & (US$ Million) Table 65. Europe MRD (Minimal Residual Disease) Testing Revenue by Application (2023-2028) & (US$ Million) Table 66. Europe MRD (Minimal Residual Disease) Testing Sales by Country (2017-2022) & (Units) Table 67. Europe MRD (Minimal Residual Disease) Testing Sales by Country (2023-2028) & (Units) Table 68. Europe MRD (Minimal Residual Disease) Testing Revenue by Country (2017-2022) & (US$ Million) Table 69. Europe MRD (Minimal Residual Disease) Testing Revenue by Country (2023-2028) & (US$ Million) Table 70. Asia Pacific MRD (Minimal Residual Disease) Testing Sales by Type (2017-2022) & (Units) Table 71. Asia Pacific MRD (Minimal Residual Disease) Testing Sales by Type (2023-2028) & (Units) Table 72. Asia Pacific MRD (Minimal Residual Disease) Testing Revenue by Type (2017-2022) & (US$ Million) Table 73. Asia Pacific MRD (Minimal Residual Disease) Testing Revenue by Type (2023-2028) & (US$ Million) Table 74. Asia Pacific MRD (Minimal Residual Disease) Testing Sales by Application (2017-2022) & (Units) Table 75. Asia Pacific MRD (Minimal Residual Disease) Testing Sales by Application (2023-2028) & (Units) Table 76. Asia Pacific MRD (Minimal Residual Disease) Testing Revenue by Application (2017-2022) & (US$ Million) Table 77. Asia Pacific MRD (Minimal Residual Disease) Testing Revenue by Application (2023-2028) & (US$ Million) Table 78. Asia Pacific MRD (Minimal Residual Disease) Testing Sales by Region (2017-2022) & (Units) Table 79. Asia Pacific MRD (Minimal Residual Disease) Testing Sales by Region (2023-2028) & (Units) Table 80. Asia Pacific MRD (Minimal Residual Disease) Testing Revenue by Region (2017-2022) & (US$ Million) Table 81. Asia Pacific MRD (Minimal Residual Disease) Testing Revenue by Region (2023-2028) & (US$ Million) Table 82. Latin America MRD (Minimal Residual Disease) Testing Sales by Type (2017-2022) & (Units) Table 83. Latin America MRD (Minimal Residual Disease) Testing Sales by Type (2023-2028) & (Units) Table 84. Latin America MRD (Minimal Residual Disease) Testing Revenue by Type (2017-2022) & (US$ Million) Table 85. Latin America MRD (Minimal Residual Disease) Testing Revenue by Type (2023-2028) & (US$ Million) Table 86. Latin America MRD (Minimal Residual Disease) Testing Sales by Application (2017-2022) & (Units) Table 87. Latin America MRD (Minimal Residual Disease) Testing Sales by Application (2023-2028) & (Units) Table 88. Latin America MRD (Minimal Residual Disease) Testing Revenue by Application (2017-2022) & (US$ Million) Table 89. Latin America MRD (Minimal Residual Disease) Testing Revenue by Application (2023-2028) & (US$ Million) Table 90. Latin America MRD (Minimal Residual Disease) Testing Sales by Country (2017-2022) & (Units) Table 91. Latin America MRD (Minimal Residual Disease) Testing Sales by Country (2023-2028) & (Units) Table 92. Latin America MRD (Minimal Residual Disease) Testing Revenue by Country (2017-2022) & (US$ Million) Table 93. Latin America MRD (Minimal Residual Disease) Testing Revenue by Country (2023-2028) & (US$ Million) Table 94. Middle East and Africa MRD (Minimal Residual Disease) Testing Sales by Type (2017-2022) & (Units) Table 95. Middle East and Africa MRD (Minimal Residual Disease) Testing Sales by Type (2023-2028) & (Units) Table 96. Middle East and Africa MRD (Minimal Residual Disease) Testing Revenue by Type (2017-2022) & (US$ Million) Table 97. Middle East and Africa MRD (Minimal Residual Disease) Testing Revenue by Type (2023-2028) & (US$ Million) Table 98. Middle East and Africa MRD (Minimal Residual Disease) Testing Sales by Application (2017-2022) & (Units) Table 99. Middle East and Africa MRD (Minimal Residual Disease) Testing Sales by Application (2023-2028) & (Units) Table 100. Middle East and Africa MRD (Minimal Residual Disease) Testing Revenue by Application (2017-2022) & (US$ Million) Table 101. Middle East and Africa MRD (Minimal Residual Disease) Testing Revenue by Application (2023-2028) & (US$ Million) Table 102. Middle East and Africa MRD (Minimal Residual Disease) Testing Sales by Country (2017-2022) & (Units) Table 103. Middle East and Africa MRD (Minimal Residual Disease) Testing Sales by Country (2023-2028) & (Units) Table 104. Middle East and Africa MRD (Minimal Residual Disease) Testing Revenue by Country (2017-2022) & (US$ Million) Table 105. Middle East and Africa MRD (Minimal Residual Disease) Testing Revenue by Country (2023-2028) & (US$ Million) Table 106. ICON plc Corporation Information Table 107. ICON plc Description and Major Businesses Table 108. ICON plc MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 109. ICON plc MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications Table 110. ICON plc Recent Developments Table 111. ArcherDX(Invitae) Corporation Information Table 112. ArcherDX(Invitae) Description and Major Businesses Table 113. ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 114. ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications Table 115. ArcherDX(Invitae) Recent Developments Table 116. ARUP Laboratories Corporation Information Table 117. ARUP Laboratories Description and Major Businesses Table 118. ARUP Laboratories MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 119. ARUP Laboratories MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications Table 120. ARUP Laboratories Recent Developments Table 121. Asuragen Corporation Information Table 122. Asuragen Description and Major Businesses Table 123. Asuragen MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 124. Asuragen MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications Table 125. Asuragen Recent Developments Table 126. Cergentis B.V. Corporation Information Table 127. Cergentis B.V. Description and Major Businesses Table 128. Cergentis B.V. MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 129. Cergentis B.V. MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications Table 130. Cergentis B.V. Recent Developments Table 131. Bio-Rad Laboratories Corporation Information Table 132. Bio-Rad Laboratories Description and Major Businesses Table 133. Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 134. Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications Table 135. Bio-Rad Laboratories Recent Developments Table 136. Mission Bio Corporation Information Table 137. Mission Bio Description and Major Businesses Table 138. Mission Bio MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 139. Mission Bio MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications Table 140. Mission Bio Recent Developments Table 141. Guardant Health Corporation Information Table 142. Guardant Health Description and Major Businesses Table 143. Guardant Health MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 144. Guardant Health MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications Table 145. Guardant Health Recent Developments Table 146. Invivoscribe Corporation Information Table 147. Invivoscribe Description and Major Businesses Table 148. Invivoscribe MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 149. Invivoscribe MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications Table 150. Invivoscribe Recent Developments Table 151. LabCorp Corporation Information Table 152. LabCorp Description and Major Businesses Table 153. LabCorp MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 154. LabCorp MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications Table 155. LabCorp Recent Developments Table 156. Inivata Corporation Information Table 157. Inivata Description and Major Businesses Table 158. Inivata MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 159. Inivata MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications Table 160. Inivata Recent Developments Table 161. Natera Corporation Information Table 162. Natera Description and Major Businesses Table 163. Natera MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 164. Natera MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications Table 165. Natera Recent Developments Table 166. NeoGenomics Laboratories Corporation Information Table 167. NeoGenomics Laboratories Description and Major Businesses Table 168. NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 169. NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications Table 170. NeoGenomics Laboratories Recent Developments Table 171. Opko Health Corporation Information Table 172. Opko Health Description and Major Businesses Table 173. Opko Health MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 174. Opko Health MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications Table 175. Opko Health Recent Developments Table 176. Quest Diagnostics Corporation Information Table 177. Quest Diagnostics Description and Major Businesses Table 178. Quest Diagnostics MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 179. Quest Diagnostics MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications Table 180. Quest Diagnostics Recent Developments Table 181. Sysmex Corporation Corporation Information Table 182. Sysmex Corporation Description and Major Businesses Table 183. Sysmex Corporation MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 184. Sysmex Corporation MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications Table 185. Sysmex Corporation Recent Developments Table 186. Adaptive Biotechnologies Corporation Information Table 187. Adaptive Biotechnologies Description and Major Businesses Table 188. Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 189. Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Product Model Numbers, Pictures, Descriptions and Specifications Table 190. Adaptive Biotechnologies Recent Developments Table 191. Key Raw Materials Lists Table 192. Raw Materials Key Suppliers Lists Table 193. MRD (Minimal Residual Disease) Testing Distributors List Table 194. MRD (Minimal Residual Disease) Testing Customers List Table 195. MRD (Minimal Residual Disease) Testing Market Trends Table 196. MRD (Minimal Residual Disease) Testing Market Drivers Table 197. MRD (Minimal Residual Disease) Testing Market Challenges Table 198. MRD (Minimal Residual Disease) Testing Market Restraints Table 199. Research Programs/Design for This Report Table 200. Key Data Information from Secondary Sources Table 201. Key Data Information from Primary Sources List of Figures Figure 1. MRD (Minimal Residual Disease) Testing Product Picture Figure 3. Global MRD (Minimal Residual Disease) Testing Market Share by Type in 2021 & 2028 Figure 3. Flow Cytometry Product Picture Figure 4. Polymerase Chain Reaction (PCR) Product Picture Figure 5. Next-Generation Sequencing (NGS) Product Picture Figure 6. Global MRD (Minimal Residual Disease) Testing Market Share by Application in 2021 & 2028 Figure 7. Specialty Clinics and Hospitals Figure 8. Diagnostic Laboratories Figure 9. Research Institutions Figure 10. MRD (Minimal Residual Disease) Testing Report Years Considered Figure 11. Global MRD (Minimal Residual Disease) Testing Sales 2017-2028 (Units) Figure 12. Global MRD (Minimal Residual Disease) Testing Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global MRD (Minimal Residual Disease) Testing Revenue 2017-2028 (US$ Million) Figure 14. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Region in Percentage: 2021 Versus 2028 Figure 15. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Region (2017-2022) Figure 16. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Region (2023-2028) Figure 17. North America MRD (Minimal Residual Disease) Testing Sales YoY (2017-2028) & (Units) Figure 18. North America MRD (Minimal Residual Disease) Testing Revenue YoY (2017-2028) & (US$ Million) Figure 19. Europe MRD (Minimal Residual Disease) Testing Sales YoY (2017-2028) & (Units) Figure 20. Europe MRD (Minimal Residual Disease) Testing Revenue YoY (2017-2028) & (US$ Million) Figure 21. Asia-Pacific MRD (Minimal Residual Disease) Testing Sales YoY (2017-2028) & (Units) Figure 22. Asia-Pacific MRD (Minimal Residual Disease) Testing Revenue YoY (2017-2028) & (US$ Million) Figure 23. Latin America MRD (Minimal Residual Disease) Testing Sales YoY (2017-2028) & (Units) Figure 24. Latin America MRD (Minimal Residual Disease) Testing Revenue YoY (2017-2028) & (US$ Million) Figure 25. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales YoY (2017-2028) & (Units) Figure 26. Middle East & Africa MRD (Minimal Residual Disease) Testing Revenue YoY (2017-2028) & (US$ Million) Figure 27. The MRD (Minimal Residual Disease) Testing Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021 Figure 28. The Top 5 and 10 Largest Manufacturers of MRD (Minimal Residual Disease) Testing in the World: Market Share by MRD (Minimal Residual Disease) Testing Revenue in 2021 Figure 29. Global MRD (Minimal Residual Disease) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021 Figure 30. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2017-2028) Figure 31. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Type (2017-2028) Figure 32. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2017-2028) Figure 33. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Application (2017-2028) Figure 34. North America MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2017-2028) Figure 35. North America MRD (Minimal Residual Disease) Testing Revenue Market Share by Type (2017-2028) Figure 36. North America MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2017-2028) Figure 37. North America MRD (Minimal Residual Disease) Testing Revenue Market Share by Application (2017-2028) Figure 38. North America MRD (Minimal Residual Disease) Testing Sales Share by Country (2017-2028) Figure 39. North America MRD (Minimal Residual Disease) Testing Revenue Share by Country (2017-2028) Figure 40. United States MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million) Figure 41. Canada MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million) Figure 42. Europe MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2017-2028) Figure 43. Europe MRD (Minimal Residual Disease) Testing Revenue Market Share by Type (2017-2028) Figure 44. Europe MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2017-2028) Figure 45. Europe MRD (Minimal Residual Disease) Testing Revenue Market Share by Application (2017-2028) Figure 46. Europe MRD (Minimal Residual Disease) Testing Sales Share by Country (2017-2028) Figure 47. Europe MRD (Minimal Residual Disease) Testing Revenue Share by Country (2017-2028) Figure 48. Germany MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million) Figure 49. France MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million) Figure 50. U.K. MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million) Figure 51. Italy MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million) Figure 52. Russia MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million) Figure 53. Asia Pacific MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2017-2028) Figure 54. Asia Pacific MRD (Minimal Residual Disease) Testing Revenue Market Share by Type (2017-2028) Figure 55. Asia Pacific MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2017-2028) Figure 56. Asia Pacific MRD (Minimal Residual Disease) Testing Revenue Market Share by Application (2017-2028) Figure 57. Asia Pacific MRD (Minimal Residual Disease) Testing Sales Share by Region (2017-2028) Figure 58. Asia Pacific MRD (Minimal Residual Disease) Testing Revenue Share by Region (2017-2028) Figure 59. China MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million) Figure 60. Japan MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million) Figure 61. South Korea MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million) Figure 62. India MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million) Figure 63. Australia MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million) Figure 64. China Taiwan MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million) Figure 65. Indonesia MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million) Figure 66. Thailand MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million) Figure 67. Malaysia MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million) Figure 68. Latin America MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2017-2028) Figure 69. Latin America MRD (Minimal Residual Disease) Testing Revenue Market Share by Type (2017-2028) Figure 70. Latin America MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2017-2028) Figure 71. Latin America MRD (Minimal Residual Disease) Testing Revenue Market Share by Application (2017-2028) Figure 72. Latin America MRD (Minimal Residual Disease) Testing Sales Share by Country (2017-2028) Figure 73. Latin America MRD (Minimal Residual Disease) Testing Revenue Share by Country (2017-2028) Figure 74. Mexico MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million) Figure 75. Brazil MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million) Figure 76. Argentina MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million) Figure 77. Middle East and Africa MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2017-2028) Figure 78. Middle East and Africa MRD (Minimal Residual Disease) Testing Revenue Market Share by Type (2017-2028) Figure 79. Middle East and Africa MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2017-2028) Figure 80. Middle East and Africa MRD (Minimal Residual Disease) Testing Revenue Market Share by Application (2017-2028) Figure 81. Middle East and Africa MRD (Minimal Residual Disease) Testing Sales Share by Country (2017-2028) Figure 82. Middle East and Africa MRD (Minimal Residual Disease) Testing Revenue Share by Country (2017-2028) Figure 83. Turkey MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million) Figure 84. Saudi Arabia MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million) Figure 85. UAE MRD (Minimal Residual Disease) Testing Revenue (2017-2028) & (US$ Million) Figure 86. MRD (Minimal Residual Disease) Testing Value Chain Figure 87. MRD (Minimal Residual Disease) Testing Production Process Figure 88. Channels of Distribution Figure 89. Distributors Profiles Figure 90. Bottom-up and Top-down Approaches for This Report Figure 91. Data Triangulation Figure 92. Key Executives Interviewed

ICON plc ArcherDX(Invitae) ARUP Laboratories Asuragen Cergentis B.V. Bio-Rad Laboratories Mission Bio Guardant Health Invivoscribe LabCorp Inivata Natera NeoGenomics Laboratories Opko Health Quest Diagnostics Sysmex Corporation Adaptive Biotechnologies